BEONE MEDICINES UK, LTD.

Active London

Research and experimental development on biotechnology

58 employees website.com
Life sciences and medical technology Research and experimental development on biotechnology
B

BEONE MEDICINES UK, LTD.

Research and experimental development on biotechnology

Founded 14 Dec 2018 Active London, United Kingdom 58 employees website.com
Life sciences and medical technology Research and experimental development on biotechnology

Previous Company Names

BEIGENE UK, LTD. 14 Dec 2018 — 12 May 2025
Accounts Submitted 27 Oct 2025 Next due 30 Sept 2026 4 months remaining
Confirmation Submitted 3 Oct 2025 Next due 4 Oct 2026 4 months remaining
Net assets £504M £102M 2024 year on year
Total assets £521M £116M 2024 year on year
Total Liabilities £17M £14M 2024 year on year
Charges 1
1 outstanding

Contact & Details

Contact

Registered Address

Regus - London Paddington - 2 Kingdom Street London W2 6BD United Kingdom

Website

www.example.com

Full company profile for BEONE MEDICINES UK, LTD. (11726698), an active life sciences and medical technology company based in London, United Kingdom. Incorporated 14 Dec 2018. Research and experimental development on biotechnology. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Jan → 31 Dec 2024
Type full
Next accounts 31 Dec 2025
Due by 30 Sept 2026 4 months remaining

Balance Sheet & P&L (2019–2024)

Cash in Bank

£2.65M

Increased by £2.30M (+671%)

Net Assets

£503.76M

Increased by £102.12M (+25%)

Total Liabilities

£17.15M

Increased by £14.09M (+460%)

Turnover

£31.44M

Increased by £14.69M (+88%)

Employees

58

Increased by 12 (+26%)

Debt Ratio

3%

Increased by 2 (+200%)

Financial History

Revenue, profit, EBITDA and key financial figures

2024
31 Dec Year End
2023
31 Dec Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

No fundraising or grants recorded

Investors (0)

No investor information available

Share Capital

Share Capital

Share allotments and capital structure

13 Allotments 13 Shares £323.35m Total
Date FromShare ClassShares AllottedAmount RaisedPrice/Share
3 Jun 20241£783k£783k
28 Mar 20241£1.42m£1.42m
4 Mar 20241£1.53m£1.53m
19 Feb 20241£1.59m£1.59m
9 Feb 20241£1.97m£1.97m

Officers

Officers

0 active 3 resigned
Status

No officers found

No officers found

Shareholders

Shareholders (2)

Bg Nc 2, Ltd
86.4%
133
Beone Medicines Ltd
13.6%
21

Persons with Significant Control

Persons with Significant Control (1)

1 Active

Beigene, Ltd.

Unknown

Active
Notified 14 Dec 2018
Nature of Control
  • Significant Influence Or Control

Group Structure

Group Structure

BEONE MEDICINES UK, LTD. Current Company

Charges

Charges

1 outstanding

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
27 Dec 2025Persons With Significant ControlChange to Beone Medicines Ltd. as a person with significant control on 14 Dec 2018
18 Dec 2025OfficersAppointment of Jeffrey William Naven as director on 18 Dec 2025
24 Nov 2025MortgageMortgage Create With Deed With Charge Number Charge Creation Date
27 Oct 2025AccountsAnnual accounts made up to 31 Dec 2024
3 Oct 2025Confirmation StatementConfirmation statement made on 20 Sept 2025 with updates
27 Dec 2025 Persons With Significant Control

Change to Beone Medicines Ltd. as a person with significant control on 14 Dec 2018

18 Dec 2025 Officers

Appointment of Jeffrey William Naven as director on 18 Dec 2025

24 Nov 2025 Mortgage

Mortgage Create With Deed With Charge Number Charge Creation Date

27 Oct 2025 Accounts

Annual accounts made up to 31 Dec 2024

3 Oct 2025 Confirmation Statement

Confirmation statement made on 20 Sept 2025 with updates

Recent Activity

Latest Activity

Change to Beone Medicines Ltd. as a person with significant control on 14 Dec 2018

5 months ago on 27 Dec 2025

Appointment of Jeffrey William Naven as director on 18 Dec 2025

5 months ago on 18 Dec 2025

Mortgage Create With Deed With Charge Number Charge Creation Date

6 months ago on 24 Nov 2025

Annual accounts made up to 31 Dec 2024

7 months ago on 27 Oct 2025

Confirmation statement made on 20 Sept 2025 with updates

7 months ago on 3 Oct 2025